Importantly, in multiple model systems, the Ras-driven pathway of oncogenic transformation was shown to depend on the function of RAC1 and its immediate downstream effector PAK1 [26,27,29,52,53], representing a potentially exploitable vulnerability in a subset of cancers [20,54]. Here, RAC1 is linked to cancer.